Product Information
CARVEDILOL 3.125 MG TABLET is a generic product labeled by Unichem Pharmaceuticals (USA) Inc., priced at $0.0168 per EA under NDC 76385011050. Its NADAC has been published 514 times since Oct 19, 2016.
FDA first approved this application on Sep 5, 2007. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the Carvedilol market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
3.125 mg/1
Manufacturer
Unichem Pharmaceuticals (USA) Inc.NDC
76385011050
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
CARVEDILOLApproval Type
Generic (ANDA)
FDA Application
ANDA078384FDA Approved
9/5/2007
TE Code
AB
On Market Since
10/1/2016
Pharmacological Classes
Price Statistics
The NADAC for CARVEDILOL 3.125 MG TABLET has been published 514 times since Oct 19, 2016, and over the history we have for it it has declined 42.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0168 per EA |
|---|---|
| All-time high | $0.0291 (Mar 15, 2017) |
| All-time low | $0.0133 (Nov 20, 2024) |
| 52-week high | $0.0174 |
| 52-week low | $0.0163 |
| Median price | $0.0212 |
| Average price | $0.0213 |
| Largest weekly change | -22.2% (Nov 20, 2024) |
| Weeks tracked | 514 |
| Tracking since | Oct 19, 2016 |
Generic Alternatives
The matcher finds 9 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of CARVEDILOL 3.125 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CARVEDILOL 3.125 MG TABLET, manufactured by Unichem Pharmaceuticals (USA) Inc., is $0.0168 per EA (NDC 76385011050), effective Aug 19, 2026.
How has the price of CARVEDILOL 3.125 MG TABLET changed over time?
Over the history we have for it, the NADAC for CARVEDILOL 3.125 MG TABLET has declined 42.3%. It has been tracked across 514 weekly CMS publications since Oct 19, 2016.
What are the highest and lowest recorded NADAC prices for CARVEDILOL 3.125 MG TABLET?
Since Oct 19, 2016, the NADAC for CARVEDILOL 3.125 MG TABLET has ranged from a low of $0.0133 (Nov 20, 2024) to a high of $0.0291 (Mar 15, 2017), with a median of $0.0212 per EA.
Are there cheaper alternatives to CARVEDILOL 3.125 MG TABLET?
9 manufacturers publish a NADAC-priced product with the same active ingredient and strength as CARVEDILOL 3.125 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures CARVEDILOL 3.125 MG TABLET?
CARVEDILOL 3.125 MG TABLET (NDC 76385011050) is labeled by Unichem Pharmaceuticals (USA) Inc., and CMS classifies it as a generic product.